부산대학교 도서관

Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Lawler K; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Barrett JE; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Rowley M; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Saddle Point Science Ltd, London, UK.; Rodriguez-Justo M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Fisher D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Gao F; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Tullis IDC; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Deng J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Brown L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Kaplan R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Hochhauser D; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Adams R; School of Medicine, Cardiff University, Cardiff, UK.; Maughan TS; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Vojnovic B; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Coolen ACC; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Saddle Point Science Ltd, London, UK.; Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital King's College London, London, UK.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Weill Cornell Medical College, New York, New York.; Michelini F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Misale S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Cocco E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Baldino L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Cai Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Shifman S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tu HY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.; Myers ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Xu C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.; Mattar M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Khodos I; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Little M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Qeriqi B; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Weitsman G; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; Wilhem CJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Lalani AS; Puma Biotechnology, Los Angeles, California.; Diala I; Puma Biotechnology, Los Angeles, California.; Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Berger MF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Barber PR; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Ng T; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Isbell JM; Weill Cornell Medical College, New York, New York.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Jones DR; Weill Cornell Medical College, New York, New York.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Yu HA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Thyparambil S; mProbe Inc., Rockville, Maryland.; Liao WL; mProbe Inc., Rockville, Maryland.; Bhalkikar A; mProbe Inc., Rockville, Maryland.; Cecchi F; AstraZeneca, Gaithersburg, Maryland.; Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Lewis JS; Weill Cornell Medical College, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Radiochemistry and Molecular Imaging Probe Core, Memorial Sloan Kettering Cancer Center, New York, New York.; Buonocore DJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Ho AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Razavi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Poirier JT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Tsurutani J; Advanced Cancer Translational Research Institute, Department of Medical Oncology, Showa University, Tokyo, Japan.; Ulaner GA; Weill Cornell Medical College, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; mProbe Inc., Rockville, Maryland.; de Stanchina E; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Rosen N; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular-Based Therapy, Memorial Sloan Kettering Cancer Center, New York, New York.; Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Scaltriti M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular-Based Therapy, Memorial Sloan Kettering Cancer Center, New York, New York.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Levitt JA; Microscopy Innovation Centre, Guy's Campus, Kings College, London, SE1 1UL, UK.; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK.; Poland SP; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK.; Krstajic N; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Pfisterer K; Randall Centre for Cell and Molecular Biophysics, Guy's Campus, Kings College, London, SE1 1UL, UK.; Erdogan A; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Parsons M; Randall Centre for Cell and Molecular Biophysics, Guy's Campus, Kings College, London, SE1 1UL, UK.; Henderson RK; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Ameer-Beg SM; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK. simon.ameer-beg@kcl.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Singh AN; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Oehler J; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Torrecilla I; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Kilgas S; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Li S; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Vaz B; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Guérillon C; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.; Fielden J; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Hernandez-Carralero E; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Cabrera E; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Tullis ID; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Meerang M; Institute of Pharmacology and Toxicology-Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.; Barber PR; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Freire R; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Universidad Fernando Pessoa Canarias, Santa Maria de Guia, Spain.; Parsons J; Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, UK.; Vojnovic B; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Kiltie AE; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Mailand N; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.; Ramadan K; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Publisher: Wiley Blackwell Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

Mandeville HC; Ng QS; Daley FM; Barber PR; Pierce G; Finch J; Burke M; Bell A; Townsend ER; Kozarski R; Vojnovic B; Hoskin PJ; Goh V; Mandeville, Henry C; Ng, Quan Sing; Daley, Frances M; Barber, Paul R; Pierce, Glenn; Finch, Jessica; Burke, Margaret; et al

Radiology (RADIOLOGY), 2012 Aug; 264(2): 581-589. (9p)

Monypenny J; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Milewicz H; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Flores-Borja F; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK.; Weitsman G; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Cheung A; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK.; Chowdhury R; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, Great Maze Pond, London, UK.; Burgoyne T; UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.; Arulappu A; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Lawler K; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Barber PR; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.; Vicencio JM; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.; Keppler M; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Wulaningsih W; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK.; Davidson SM; Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London WC1E 6HX, UK.; Fraternali F; Bioinformatics and Computational Biology, Randall Division, King's College London, Guy's Medical School Campus, London SE1 1UL, UK.; Woodman N; KHP Cancer Biobank, King's College London, Innovation Hub, Guy's Cancer Centre, London SE1 9RT, UK.; Turmaine M; Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.; Gillett C; KHP Cancer Biobank, King's College London, Innovation Hub, Guy's Cancer Centre, London SE1 9RT, UK.; Franz D; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.; Quezada SA; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.; Futter CE; UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.; Von Kriegsheim A; Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland.; Kolch W; Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland; Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland; School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.; Vojnovic B; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.; Carlton JG; Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, Great Maze Pond, London, UK; Organelle Dynamics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: jeremy.carlton@kcl.ac.uk.; Ng T; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK. Electronic address: tony.ng@kcl.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Claus J; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, United Kingdom.; Patel G; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer Studies, Kings College London, London, United Kingdom.; Sussex Cancer Centre, Brighton and Sussex University Hospitals, Brighton, United States.; Autore F; Randall Division of Cell & Molecular Biophysics, Kings College London, London, United Kingdom.; Colomba A; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, United Kingdom.; Weitsman G; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer Studies, Kings College London, London, United Kingdom.; Soliman TN; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, United Kingdom.; Roberts S; Central Laser Facility, Research Complex at Harwell, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Didcot, United Kingdom.; Zanetti-Domingues LC; Central Laser Facility, Research Complex at Harwell, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Didcot, United Kingdom.; Hirsch M; Central Laser Facility, Research Complex at Harwell, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Didcot, United Kingdom.; Collu F; Randall Division of Cell & Molecular Biophysics, Kings College London, London, United Kingdom.; George R; The Structural Biology Science Technology Platform, The Francis Crick Institute, London, United Kingdom.; Ortiz-Zapater E; Department of Asthma, Allergy and Respiratory Science, King's College London, Guy's Hospital, London, United Kingdom.; Barber PR; Randall Division of Cell & Molecular Biophysics, Kings College London, London, United Kingdom.; UCL Cancer Institute, University College London, London, United Kingdom.; Vojnovic B; Randall Division of Cell & Molecular Biophysics, Kings College London, London, United Kingdom.; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom.; Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Martin-Fernandez ML; Central Laser Facility, Research Complex at Harwell, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Didcot, United Kingdom.; Cameron A; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, United Kingdom.; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Fraternali F; Randall Division of Cell & Molecular Biophysics, Kings College London, London, United Kingdom.; Ng T; Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer Studies, Kings College London, London, United Kingdom.; UCL Cancer Institute, University College London, London, United Kingdom.; Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital King's College London School of Medicine, London, United Kingdom.; Parker PJ; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Campus, London, United Kingdom.

Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

Weitsman G; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Mitchell NJ; Department of Chemistry, University College London, London, UK.; Evans R; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Cheung A; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Breast Cancer Now Research Unit, King's College London, London, UK.; Kalber TL; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.; Bofinger R; Department of Chemistry, University College London, London, UK.; Fruhwirth GO; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Keppler M; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Wright ZVF; Department of Chemistry, University College London, London, UK.; Barber PR; Gray Laboratories, Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK.; Gordon P; Breast Cancer Now Research Unit, King's College London, London, UK.; de Koning T; Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Wulaningsih W; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK.; Sander K; Institute of Nuclear Medicine, University College London, London, UK.; Vojnovic B; Gray Laboratories, Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK.; Ameer-Beg S; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Lythgoe M; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.; Arnold JN; Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Årstad E; Institute of Nuclear Medicine, University College London, London, UK.; Festy F; King's College London Dental Institute, Tissue Engineering and Biophotonics, Guy's Hospital Campus, London, UK.; Hailes HC; Department of Chemistry, University College London, London, UK.; Tabor AB; Department of Chemistry, University College London, London, UK.; Ng T; Richard Dimbleby Department of Cancer Research, Randall Division &Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London, UK.; Breast Cancer Now Research Unit, King's College London, London, UK.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Volpi D; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Tullis IDC; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Barber PR; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Augustyniak EM; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Smart SC; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Vallis KA; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.; Vojnovic B; CR-UK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.

Publisher: Optica Publishing Group Country of Publication: United States NLM ID: 101540630 Publication Model: eCollection Cited Medium: Print ISSN: 2156-7085 (Print) Linking ISSN: 21567085 NLM ISO Abbreviation: Biomed Opt Express Subsets: PubMed not MEDLINE

Irshad S; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Flores-Borja F; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Lawler K; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Monypenny J; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Evans R; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Male V; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Gordon P; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Cheung A; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Gazinska P; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Noor F; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Wong F; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Grigoriadis A; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; Fruhwirth GO; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Leukocyte Dynamics Group, Beatson Advanced Imaging Resource, CRUK Beatson Institute, Glasgow, United Kingdom.; Barber PR; Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, United Kingdom.; Woodman N; King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.; Patel D; International Center for Infectiology Research, University of Lyon, Lyon, France.; Rodriguez-Justo M; International Center for Infectiology Research, University of Lyon, Lyon, France.; Owen J; King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.; Martin SG; Division of Cancer and Stem Cells, Department of Clinical Oncology, School of Medicine, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Pinder SE; King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.; Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, United Kingdom.; Gillett CE; King's Health Partners Cancer Biobank, King's College London, London, United Kingdom.; Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, United Kingdom.; Poland SP; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; Ameer-Beg S; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; McCaughan F; Department of Asthma, Allergy, and Lung Biology, King's College London, London, United Kingdom.; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.; Carlin LM; Leukocyte Dynamics Group, Beatson Advanced Imaging Resource, CRUK Beatson Institute, Glasgow, United Kingdom.; Hasan U; International Center for Infectiology Research, University of Lyon, Lyon, France.; Withers DR; MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Lane P; MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Vojnovic B; Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, United Kingdom.; Quezada SA; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Ellis P; Department of Medical Oncology, Guy's and St Thomas Foundation Trust, London, United Kingdom.; Tutt AN; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom.; ICR, BCN Research Unit, Toby Robins Research Centre, London, United Kingdom.; Ng T; Breast Cancer Now (BCN) Research Unit, King's College London, London, United Kingdom. tony.ng@kcl.ac.uk.; Richard Dimbleby, Randall Division & Division of Cancer Studies, King's College London, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE